A comparison of prevalence of premenstrual syndrome symptoms between athlete and non-athlete female students

1- Trout, K. K., Basel-Brown, L., Rickels, M. R.,
Schutta, M. H., Petrova, M. Freeman, E. W.,
Tkacs, N. C. and Teff, T. L. (2008). Insulin
Sensitivity, Food Intake, and Cravings with
Premenstrual Syndrome: A Pilot Study. Journal
of Women’s health. 17: 657-665.
2- Henshaw, C. A. (2007). PMS: diagnosis,
aetiology, assessment and management.
Advances in psychiatric treatment. 13: 139-146.
3- Frackiewicz, E. J. and Shiovitz, T. M. (2001).
Evaluation and management of premenstrual
syndrome and premenstrual dysphonic disorder.
Journal of the American Pharmacists
Association. 41: 437-447.
4- Wyatt, K, M., Dimmock, P. W., Jones, P. W. and
O’brien, P. M. S. (2001). Efficacy of
progesterone and progestogens in management
of premenstrual syndrome: Systematic review,
British Medical Journal. 323: 776-791.
5- Steiner, M. M. D. (2000). Premenstrual syndrome
and premenstrual dysphonic disorder: Guidelines
for management. Journal of psychiatry &
neuroscience. 25: 459-468.
6- Antal, A. B., Udezi, A. W., Ekanem, E. E., Okon,
U. J. and Umoiyoho, A. U. (2004), Premenstrual
syndrome: Prevalence in students of the
University of Calabar, Nigeria. African journal
of biomedical research. 7: 45-50.
7- Wyatt, K, M., Dimmock, P. W., Jones, P. W. and
O’brien, P. M. S. (1999). Efficacy of vitamin B-6
in the treatment of premenstrual syndrome:
Systematic review, British Medical Journal. 318:
1375-1381.
8- Yonkers, K. A. (1997). The association between
premenstrual dysphonic disorder and other mood
disorders. Journal of clinical psychiatry. 59: 19-
25.
9- Pray, W. S. (1998). PMS: A disorder that is
diagnosable. US Pharmacist. 23 (9).
nn1B     .(1384) .$Bnn. nn 7 &Bnn8  nn$B% &
nn< -10
3
(n$) ) (PMS) 7+
8 $ O‘8 ":1 $$B
.=n 
     BF &
’($) "+ B( . = 
     BF &
’($)
.559-568 ,
E56 X2  1 &
*@ X=:% <
11- Eriksson, E. (1999). Serotonin reuptake
inhibitors for the treatment of premenstrual
dysphoria. International clinical
psychopharmacology. 14: 27-31.
12- Lichten, E. M. (2005). Medical treatment of
PMS. Available from: [http//: www.
Usdoctor.com/pms.htm].
13- Patrick, J. B. (2001). Decrease in PMS
symptoms from exercising. Journal Psychosocial
Nursing. 4: 25-32.
207 .
’($) 
H@B K  
H@ 3$BIJ) ) 7+
8 $ 9 % ":1 =>#+ ? @  ;
A
14- Douglas, S. M. D. (2002). Premenstrual
syndrome evidence based treatment in family
practice. Canadian family physician. 48: 1789-
1797.
15- Rossignol, A. M. and Bonnlander, H. (1991).
Prevalence and severity of the premenstrual
syndrome. Effects of foods and beverages that
are sweet or high in sugar content. The journal of
reproductive medicine. 36: 131-136.
.(1386) M ;nnE#K )
nn‘+  );nn 
nn^‘H  -16
Bn     3)   &)
 % :B*F  ) B P-F  ;
A
3$BnnnIJ) 7nnn+
8 $ 9 nnn% ":nnn1 
nnn. 
(nnn
.n@ "n+ ) 9.…n% .$n.$ B4n@ 
. 3
I1B     )
.55 -70 ,
E56 X14 &
*@
17- Aganoff, B. J. A. and Boyle, G. J. (1994).
Aerobic exercise, mood states and menstrual
cycle symptoms. Journal of psychosomatic
research. 38: 183-192.
18- Ugarrize, D. N., Klingner, S. and O’Brien, S.
(1998). Premenstrual syndrome: diagnosis and
intervention. The nurse practitioner. 23: 40-52.
19- Choi, P.Y. and Salmon. P. (1995). Symptom
changes across the menstrual cycle in
competitive sportswomen, exercisers and
sedentary women. British Journal clinical
psychology. 34: 447-460.
20- Barnhart, K. and Freeman, E. (1995). A
clinician’s guide to the premenstrual syndrome.
Office gynecology. 79: 1457-1471.
21- Edward, M. L. (2000). Medical treatment of
premenstrual syndrome. Fertility and sterility.
53: 520-527.
22- Scully, D., Kremer, J., Meade, M. M., Graham,
R. and Dudgeon, K. (1998). Physical exercise
and psychological well being: a critical review.
British Journal of sports Medicine. 32: 111-120.
23- Margays, A. M. and Gomese, P. S. (2002). The
effect of regular physical activity on
premenstrual syndrome (PMS) symptoms.
Medicine & Science in Sports & Exercise. 34 (5).
X&nB 
In1
     X&B. )*E X€ ’B 3
% &
@ -24
":n1 .(1384) .n*b
 : ;n0  Mn11 
1
%
) 32 
nn     s‘FBnn 
nn.  
(nn  7nn+
8 $ 9 nn%
X18 &
*nn@ .3$Bnn$ 
Inn1B% 
:ann .3
(nn$)
.57-66 ,
E56
Bn# n+ X
nCB $‘+ "nA 0#n6 XM{2 + -25
,$B.
nRF ? n@ .(1385) .
;n$ j
/n  M @
$ 9 n% Y# Y#IJ$  7+
8 $ 9 % ":1 :  
    
n . h
‘+ :     H@% "+ 3
($) ) 7+
8
-341 ,
E5n6 X4 &
*n@ X10 Y
1 X3
7B. H@%
.335
26- Bianchi-Demicheli, F., Ludicke, F., Lucas, H.
and Chardonnens, D. (2002). Premenstrual
dysphoric disorder: current status of treatment.
Swiss Medical Weekly. 132: 574-578.
27- Redman, L. M. and Watherby, R. P. (2004).
Measuring performance during the menstrual
cycle: a model using oral contraceptives.
Medicine & science in sports & exercise. 36:
130-136.